| HOME >> BIOLOGY >> TECHNOLOGY |
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East, and Latin America Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 50
Table 25: World 11-Year Perspective for Specialty Enzymes
Consumption in Other End-Use Segments by Geographic Region -
Percentage Breakdown of Dollar Sales for US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East, and Latin
America Markets for Years 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 51
13. THE UNITED STATES 52
A.Market Analysis 52
Current and Future Analysis 52
Competitive Scenario 52
Table 26: Leading Players in the US Enzyme Market (2008):
Percentage Breakdown of Value Sales for Novozymes, Danisco,
Allergan, Genzyme, Genentech, and Others (includes
corresponding Graph/Chart) 52
Market Dynamics 53
Specialty Enzymes Market is Projected to Rise 53
Specialty Enzymes Form the Leading Enzymes Segment 53
Pharmaceuticals and Diagnostics Continue to be the Largest
Market 53
Specialty Medical Enzymes in a Myriad of Novel Applications 53
Market for Enzymes in Biotechnology 53
B.Market Analytics 54
Table 27: US Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 54
Table 28: US Historic Review for Specialty Enzymes by
Product Segment - Specialty Medical Enzymes, Polymerases,
Nucleases and Other Enzymes Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |